Treating the Opioid Epidemic: The State of Competition in the Markets for Addiction Medicine
Date:
Location:
2237 Rayburn House Office Building, Washington, DC 20515
Witnesses
Robin Feldman Esq.
Harry and Lillian Hastings Professor of Law, Director of the Institute for Innovation Law, UC Hastings College of the Law
Dr. David R. Gaugh, R. Ph.
Senior Vice President for Sciences and Regulatory Affairs, Generic Pharmaceutical Association
Dr. Eric Ketcham, M.D.
Medical Director, Emergency Department and Urgent Care, American College of Emergency Physicians, Co-Medical Director, EMS San Juan Regional Medical Center
Dr. Anne McDonald Pritchett
Vice President, Policy and Rsearch, Pharmaceutical Research and Manufacturers of America
- HHRG-114-JU05-Wstate-McDonaldPritchettA-20160922.pdf
- HHRG-114-JU05-TTF-McDonaldPritchettA-20160922.pdf
Mr. Mark Merritt
President and CEO, Pharmaceutical Care Management Association
Documents
- Hearing Notice
- HHRG-114-JU05-WList-20160922.pdf
- DEA Statement for the record
- For the record submisison
Subcommittees